Redmile Group, LLC Jazz Pharmaceuticals PLC Transaction History

Redmile Group, LLC

$1.53 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $823,567 - $989,356	6,723 Added 2.01%	341,882 $42.4 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $2.17 Million - $2.6 Million	16,214 Added 5.08%	335,159 $49 Million
Q4 2022 Feb 14, 2023	BUY	$129.72 - $159.85 $30.8 Million - $38 Million	237,481 Added 291.52%	318,945 $50.8 Million
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $1.49 Million - $1.9 Million	-11,800 Reduced 12.65%	81,464 $10.9 Million
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $3.04 Million - $3.63 Million	-21,500 Reduced 18.73%	93,264 $14.6 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $2.16 Million - $2.68 Million	16,700 Added 17.03%	114,764 $17.9 Million
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $91.5 Million - $111 Million	-763,337 Reduced 88.62%	98,064 $12.5 Million
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $167,231 - $240,227	1,300 Added 0.15%	861,401 $112 Million
Q2 2021 Aug 16, 2021	BUY	$160.2 - $186.42 $4.96 Million - $5.77 Million	30,942 Added 3.73%	860,101 $153 Million
Q1 2021 May 17, 2021	BUY	$150.19 - $173.5 $125 Million - $144 Million	829,159 New	829,159 $136 Million
Q4 2019 Feb 14, 2020	SELL	$117.65 - $153.73 $22.1 Million - $28.8 Million	-187,599 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$125.18 - $143.24 $2.4 Million - $2.75 Million	19,212 Added 11.41%	187,599 $24 Million
Q2 2019 Aug 14, 2019	SELL	$125.55 - $144.48 $12.7 Million - $14.6 Million	-101,093 Reduced 37.51%	168,387 $24 Million
Q1 2019 May 15, 2019	BUY	$121.81 - $142.95 $16.2 Million - $19 Million	132,800 Added 97.16%	269,480 $38.5 Million
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $15.7 Million - $22.5 Million	135,090 Added 8496.23%	136,680 $16.9 Million
Q2 2018 Aug 14, 2018	BUY	$146.33 - $183.18 $232,664 - $291,256	1,590 New	1,590 $274,000

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Account